Chemistry & Biochemistry Colloquium – Acid Ceramidase Inhibitors: A De Novo Drug Target and a New Class of Drug for Glioblastoma – Shama Mirza – Hosted by Peter Geissinger
Chemistry Room 180 3210 N. Cramer Street, MilwaukeeAcid Ceramidase Inhibitors: A De Novo Drug Target and a New Class of Drug for Glioblastoma Glioblastoma remains the most common malignant cancer of the central nervous system with an overall survival <1.5 years. Therapeutically resistant glioblastoma or glioblastoma stem-like... Read More